Home
Mark Schoenberg, Chief Medical Officer: UroGen Pharma URGN Sell · Filed 24/03/20
Trade details
- Type
- Insider sale
- Amount
- $168,600
- Shares · price
- 12,000 sh · $14.05 a share
- Held after
- 139,437 sh
- Stock
- UroGen Pharma URGN
- Trade date
- 24/03/18
- Filed
- 24/03/20
- Days to filing
- 2 days
Sold 7.9% of holdings
- Share of holding sold
- 7.9%
UroGen Pharma trades, last 26 weeks
What else happened in UroGen Pharma around then
Filed or reported within 30 days of the trade day · 24/02/17~24/04/17Mark Schoenberg's recent trades
- Mark Schoenberg
Planned saleUroGen Pharma
Planned saleUroGen Pharma
URGN
$38.4K
871 sh
$38.4K
Filed 09/09
Traded 09/08
- Mark Schoenberg
Planned saleUroGen Pharma
Planned saleUroGen Pharma
URGN
$2.9M
60,677 sh
$2.9M
Filed 08/20
Traded 08/20
- Mark Schoenberg
Planned sale10b5-1 planUroGen Pharma
Planned sale10b5-1 planUroGen Pharma
URGN
$400K
10,000 sh
$400K
Filed 07/09
Traded 07/09
- Mark Schoenberg
Sell10b5-1 planUroGen Pharma
Sell10b5-1 planUroGen Pharma
URGN
$350.1K
10,000 sh
$350.1K
Filed 06/24
Traded 06/22
- Mark Schoenberg
Planned sale10b5-1 planUroGen Pharma
Planned sale10b5-1 planUroGen Pharma
URGN
$350.1K
10,000 sh
$350.1K
Filed 06/22
Traded 06/22